← Open Payments lookup

CATHERINE ESTIPONA: Open Payments

NPI 1760556534 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$690 in 29 payments from 9 companies in 2025. Trend: 2023 $711 · 2024 $518 · 2025 $690

Food & beverage: $690
CompanyPaymentsAmount
ABBVIE INC.9$188
Amgen Inc.5$121
Astellas Pharma US Inc3$101
Novo Nordisk Inc4$94
PFIZER INC.3$76
Sumitomo Pharma America, Inc.2$50
Lilly USA, LLC1$23
Merck Sharp & Dohme LLC1$20
GlaxoSmithKline, LLC.1$17

Products named: VRAYLAR, Veozah, NURTEC ODT, Ozempic, KRYSTEXXA, OTEZLA, GEMTESA, MOUNJARO.

Industry payments across NV — which companies pay providers there.